<DOC>
	<DOC>NCT02798341</DOC>
	<brief_summary>TRACR will provide a data/biospecimen repository for translational research to better diagnose, prognose, treat and cure breast cancer (and related diseases/treatment conditions). Patients at the Rowan Breast Center will be consented for donation of blood and if available tumor/healthy/archived tissue. Patients will be consented to give permission to use said specimens for future research and to be contacted in the future about other research participation and additional information.</brief_summary>
	<brief_title>The Breast Program - Translational Cancer Resource</brief_title>
	<detailed_description />
	<criteria>RBC patients with known invasive cancer presurgery (greater or equal to 1.5cm) are given priority in recruitment. RBC patients with known invasive cancer presurgery (less then 1.5cm). 3. RBC patients who are postsurgery for invasive breast cancer (performed at UPHS or nonUPHS entities). Patients that are of high risk for breast cancer (family history, known deleterious genetic mutation(s)) seeking a prophylactic mastectomy at the breast clinic. Only persons who can understand and give informed consent will be eligible to participate in this study. Furthermore, no persons belonging to vulnerable populations with as children (below 18 years of age), fetuses, neonates or prisoners will be recruited in this study. Pregnant women, who are presurgery and having surgery for clinical reasons, can still be recruited for tissue and blood collection. Individual who cannot understand and give informed consent (cognitively impaired persons) Children (below 18 years of age), fetuses and neonates Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>